Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q4 FY22 results · Jan–Mar 2022
Max Healthcare Institute reported revenue from operations of ₹938.80 crore (up 17.1% from Q4 FY21) and net profit of ₹123.73 crore (up 77.5% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a consolidated basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 938.80 | 801.86 | +17.1% | 974.16 | −3.6% |
| Other income | 24.71 | 28.68 | −13.8% | 48.61 | −49.2% |
| Total income | 963.51 | 830.54 | +16.0% | 1,022.77 | −5.8% |
| Profit before tax | 154.39 | 104.47 | +47.8% | 213.04 | −27.5% |
| Net profit for the period | 123.73 | 69.69 | +77.5% | 189.75 | −34.8% |
| EPS, basic (₹) | 1.28 | 0.76 | +68.4% | 1.96 | −34.7% |
| Net margin (%) | 13.2 | 8.7 | 19.5 |
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 381.20 | 330.80 | +15.2% | 397.72 | −4.2% |
| Other income | 27.91 | 25.05 | +11.4% | 42.15 | −33.8% |
| Total income | 409.11 | 355.85 | +15.0% | 439.87 | −7.0% |
| Profit before tax | 82.54 | 30.64 | +169.4% | 109.65 | −24.7% |
| Net profit for the period | 66.15 | 7.24 | +813.7% | 103.81 | −36.3% |
| EPS, basic (₹) | 0.68 | 0.08 | +750.0% | 1.07 | −36.4% |
| Net margin (%) | 17.4 | 2.2 | 26.1 |
Consolidated
- Filed with BSE
- 26 May 2022, 15:31 IST
- Board meeting
- 25 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 26 May 2022, 15:31 IST
- Board meeting
- 25 May 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Audited
- Source
- XBRL filing on BSE